Strangelogic...
"The biggest factor here is time and the faster PNV establishes the product as std of care in as many verticals as possible, the less attractive it will be for a competitor. That is one reason IMO the BOD is pouring every spare dollar earned into expanding the customer base and uses for the product. It is also why I was delighted when they did a judicious CR to accelerate that expansion into a huge and unaddressed market such as India."
Correct. And why the CR was to vastly increase the output capacity of the production facilities.
broker recommendation, page-258
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.58 |
Change
-0.030(1.15%) |
Mkt cap ! $1.780B | |||
| Open | High | Low | Value | Volume |
| $2.61 | $2.63 | $2.57 | $1.570M | 605.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2918 | $2.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.60 | 1574 | 1 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |